Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention

Inclusion Criteria: * Subject is able to understand the information provided in the ICF and has signed the ICF. * Subject is a current non-daily user of nicotine pouches (past 30-day use) based on self-reported tobacco/nicotine-containing product use history. * Subject expresses no desire to quit consumer nicotine product use within the next 3 months from Screening visit. Exclusion Criteria: * Subject uses or intents to start using nicotine replacement therapy or any other medication for smoking cessation. * Subject uses other consumer nicotine products besides nicotine pouches more frequently than once per 30 days. * Subject with a urine cotinine test exceeding 500 ng/mL. * Subject has exhaled CO reading ≥ 10 ppm. * Subject has reasons other than medical (e.g., psychological, social reason) to not participate in the study, as determined by the Investigator. * Subject has a clinically relevant disease which requires medication or any other medical condition including clinically significant safety laboratory parameters at Screening visit, as determined by the Investigator. * Subject has a positive serology test for HIV 1/2, hepatitis B or C. * Subject has a positive urine drug test. * Subject has a positive urine alcohol test. * Subject has a visual or motor impairment that would interfere with their ability to perform a computer-based attentional task. * Subject has a current prescription for medical use of cannabis, any use of cannabis products in the past month, or inabi…